Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 223 entries
View as:

A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00804908 Org: User:
Start: 02/28/09 End: 01/31/16 Due: 01/31/17

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00707889 Org: User:
Start: 10/31/08 End: 05/31/12 Due: 05/31/13

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

Phase: N/A Priority: Normal
NCT ID: NCT01298648 Org: User:
Start: 11/30/10 End: 02/28/13 Due: 02/28/14

A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00649207 Org: User:
Start: 03/31/08 End: 03/31/13 Due: 03/31/14

A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01166282 Org: User:
Start: 09/30/10 End: 12/31/15 Due: 12/31/16

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00570986 Org: User:
Start: 11/30/07 End: 06/30/09 Due: 06/30/10

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00710580 Org: User:
Start: 07/31/08 End: 04/30/09 Due: 04/30/10

A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT01672983 Org: User:
Start: 07/31/12 End: 05/31/14 Due: 05/31/15

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00406809 Org: User:
Start: 11/30/06 End: 10/31/16 Due: 10/31/17

Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))

Phase: N/A Priority: Normal
NCT ID: NCT01163292 Org: User:
Start: 03/31/10 End: 10/31/12 Due: 10/31/13

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00335153 Org: User:
Start: 01/31/08 End: 06/30/12 Due: 06/30/13

A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01251614 Org: User:
Start: 12/31/10 End: 02/28/15 Due: 02/28/16

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01097655 Org: User:
Start: 08/31/06 End: 01/31/16 Due: 01/31/17

Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT01273519 Org: User:
Start: 01/31/11 End: 01/31/13 Due: 01/31/14

Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.

Phase: N/A Priority: Normal
NCT ID: NCT01561313 Org: User:
Start: 03/31/12 End: 11/30/12 Due: 11/30/13

A Study to Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT01149291 Org: User:
Start: 07/31/11 End: 12/31/14 Due: 12/31/15

Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01754727 Org: User:
Start: 12/31/12 End: 10/31/15 Due: 10/31/16

Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869

Phase: N/A Priority: Normal
NCT ID: NCT00733187 Org: User:
Start: 02/28/09 End: 06/30/12 Due: 06/30/13

Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA

Phase: N/A Priority: Normal
NCT ID: NCT01117480 Org: User:
Start: 07/31/05 End: 12/31/14 Due: 12/31/15

A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00528697 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies

Phase: N/A Priority: Normal
NCT ID: NCT00726882 Org: User:
Start: 08/31/08 End: 05/31/10 Due: 05/31/11

A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01345045 Org: User:
Start: 04/30/11 End: 10/31/11 Due: 10/31/12

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01589419 Org: User:
Start: 06/30/12 End: 01/31/15 Due: 01/31/16

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01356849 Org: User:
Start: 04/30/11 End: 08/31/12 Due: 08/31/13

The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01163617 Org: User:
Start: 05/31/10 End: 11/30/10 Due: 11/30/11